FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Padagis US Estradiol Gel Recall

Estradiol Gel, 0

Padagis US LLC · Minneapolis, MN

Risk level
Class II
Reported by FDA
Mar 5, 2025
Recall ID
D-0246-2025
Check your lot numberHow we source this data

Summary

Padagis US recalled Estradiol Gel starting Feb 6, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0246-2025 on Mar 5, 2025. Reason: Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product. Status: Completed.

Why it was recalled

Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.

Product description

Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton, Rx Only, For Topical Use Only, Manufactured by Padagis, Yeruham, Israel, NDC: 45802-0134-30

Lot numbers, UPCs & expiration codes

Lot # 193109; Exp. 07/31/2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0246-2025
Classification
Class II
Status
Completed
Recall initiated
Feb 6, 2025
FDA report date
Mar 5, 2025
Quantity
4944 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Padagis US LLC

Original FDA data

Every field from FDA enforcement report D-0246-2025, exactly as published.

Show all FDA fields
City
Minneapolis
State
MN
Status
Completed
Country
United States
Event ID
96245
Address
3940 Quebec Ave N
Code information
Lot # 193109; Exp. 07/31/2026
Postal code
55427-1244
Report date
Mar 5, 2025
Product type
Drugs
Recall number
D-0246-2025
Classification
Class II
Recalling firm
Padagis US LLC
Product quantity
4944 cartons
Reason for recall
Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton, Rx Only, For Topical Use Only, Manufactured by Padagis, Yeruham, Israel, NDC: 45802-0134-30
Distribution pattern
Nationwide in the USA
Recall initiation date
Feb 6, 2025
Initial firm notification
Letter
Center classification date
Feb 21, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0246-2025, published Mar 5, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls